A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic ...

The following is a summary of “Clinical Utility of Incorporating Next-Generation Sequencing Results in the Management ...

Experimental Blood Test for Pancreatic Cancer Undergoing Clinical Development and Evaluation Jan. 13, 2025 — An experimental blood test for pancreatic cancer is being evaluated by a commercial ...

High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of ...

Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients.

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

Barcelona-based Sycai Medical has closed a €3M funding round backed by LUMO Labs, Ship2B Ventures, Athos Capital, and Namarel Ventures.

With an estimated 1.5 lakh cases of oral cancer diagnosed annually in India and a high mortality rate due to late detection, ...

Today Early in the fall, experts might also see more cases of respiratory syncytial virus, Dr. Geeta Sood, assistant professor of medicine and epidemiologist at Johns Hopkins Bayview Medical Center, ...

Surufatinib plus TAS-102 showed promising survival benefits with manageable toxicity in refractory metastatic PDAC patients, ...

in first-line pancreatic cancer patients show target lesion shrinkage in all evaluable patients, including a 100% reduction (PR) - - Encouraging initial dat As the U.S. stock market navigates a ...

After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...